X T L Biopharmaceuticals reported $-479K in EBITDA for its fiscal quarter ending in December of 2024.





Ebitda Change Date
Alaunos Therapeutics USD -21.02M 1.33M Mar/2021
Bioline Rx USD -554K 2.93M Sep/2025
Teva Pharmaceutical Industries USD 1.64B 243M Dec/2025
X T L Biopharmaceuticals USD -479K 19K Dec/2024